Study of Extended Venous Thromboembolism Prevention After Abdominopelvic Cancer Surgery Observing Surgical Practices and Use of Guideline-Based Care in NCORP Network

What this Trial Is About

This research aims to evaluate the use of extended venous thromboembolism prophylaxis ePPx after abdominopelvic cancer surgery among surgeons and surgical advanced practice providers APPs within the National Cancer Institute Community Oncology Research Program NCORP network. The study focuses on understanding self-reported use of guideline-recommended ePPx and factors influencing its use across different sites and surgeon characteristics. The study is observational and includes three parts. In Part 1, surgeons and APPs complete surveys about their use of ePPx. Part 2 involves semi-structured interviews with a subset of these providers to explore barriers and facilitators to ePPx use, as well as the acceptability of decision support tools. Part 3 gathers electronic health record data from select practices to assess feasibility of identifying cancer surgery patients and their ePPx prescriptions. Participants will provide information through surveys and interviews, and data will be collected from electronic health records. Researchers will evaluate self-reported ePPx use, site and surgeon factors affecting this use, barriers and facilitators to prescribing ePPx, and the feasibility of querying electronic records. The primary outcome is the self-reported use of guideline concordant ePPx by surgeons one year after Part 1 starts. The study will continue through June 2027.

Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study